carbidopa has been researched along with Acute Disease in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (50.00) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 4 (28.57) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Adamski, P; Anielska-Michalak, E; Bartuś, S; Brycht, O; Budaj, A; Curzytek, A; Drożdż, J; Dudek, A; Gąsior, M; Gromadziński, L; Gruchała, M; Grzelakowska, K; Grzelakowski, P; Jaguszewski, M; Jankowski, P; Kamiński, L; Kasprzak, M; Kaźmierczak, J; Kleinrok, A; Kostkiewicz, M; Koziński, M; Król, P; Kryś, J; Kubica, A; Kubica, J; Kulawik, T; Legutko, J; Lesiak, M; Leszek, P; Minczew, G; Mindykowski, M; Mitkowski, P; Navarese, EP; Nessler, J; Ostrowska, M; Pawlak, A; Podhajski, P; Prokopczuk, J; Skonieczny, G; Sobkowicz, B; Sowiński, S; Stankala, S; Stolarek, W; Szymański, P; Tomaszuk-Kazberuk, A; Tycińska, A; Wester, A; Wilczewski, P; Zdrojewski, T | 1 |
Ahmad, M; Gupta, A; Rizvi, I; Zaidi, N | 1 |
Minagar, A; Shulman, LM; Weiner, WJ | 1 |
Eskey, CJ; Gardner, TB; Lewis, LD; Nierenberg, DW; Osterling, W; Reddy, NJ | 1 |
Brusa, L; Finazzi-Agrò, E; Iani, C; Miano, R; Moschella, V; Petta, F; Pisani, A; Stanzione, P | 1 |
Duggal, HS; Singh, I | 1 |
Avanzini, G; Franceschetti, S; Lombardi, B; Passerini, A | 1 |
McAuley, J; Shahmanesh, M; Swash, M | 1 |
Rózga, J; Szczerbań, J | 1 |
Rampton, DS | 1 |
Corsini, GU; Mangoni, A; Marrosu, F; Spissu, A | 1 |
Koller, WC; Lang, AE; Marsden, CD; Quinn, NP | 1 |
Ballard, PA; Langston, JW; Tetrud, JW | 1 |
Davis, BM; Davis, KL; Horvath, TB; Johns, CA; Levy, MI; Mathé, AA; Mohs, RC; Rothpearl, AB | 1 |
2 trial(s) available for carbidopa and Acute Disease
Article | Year |
---|---|
Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease.
Topics: Acute Disease; Carbidopa; Chronic Disease; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypogastric Plexus; Levodopa; Male; Middle Aged; Parasympathetic Fibers, Postganglionic; Parkinson Disease; Synaptic Transmission; Treatment Outcome; Urinary Bladder; Urinary Bladder, Neurogenic; Urination Disorders | 2007 |
Evaluating prolactin response to dopamine agonists in schizophrenia. Methodological problems.
Topics: Acute Disease; Adult; Age Factors; Apomorphine; Carbidopa; Depression, Chemical; Dopamine; Humans; Levodopa; Male; Prolactin; Research Design; Schizophrenia; Schizophrenic Psychology; Sodium Chloride | 1985 |
12 other study(ies) available for carbidopa and Acute Disease
Article | Year |
---|---|
Impact of COVID-19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV-HF-SIRIO 6 study).
Topics: Acute Disease; Carbidopa; COVID-19; Drug Combinations; Heart Failure; Humans; Levodopa; Pandemics; Retrospective Studies; SARS-CoV-2 | 2022 |
Isolated extra pontine myelinolysis presenting as acute onset parkinsonism.
Topics: Acute Disease; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Hyponatremia; Levodopa; Magnetic Resonance Imaging; Middle Aged; Myelinolysis, Central Pontine; Parkinson Disease, Secondary; Saline Solution, Hypertonic | 2012 |
Reversal of parkinsonism following liver transplantation.
Topics: Acute Disease; Aged; Antiparkinson Agents; Carbidopa; Disease Progression; Gait Disorders, Neurologic; Humans; Immunosuppressive Agents; Levodopa; Liver Cirrhosis; Liver Transplantation; Male; Parkinsonian Disorders; Remission Induction; Treatment Outcome; Tremor | 2003 |
Two cases of rapid onset Parkinson's syndrome following toxic ingestion of ethylene glycol and methanol.
Topics: Acute Disease; Adult; Aged; Antiparkinson Agents; Basal Ganglia; Carbidopa; Ethylene Glycol; Female; Humans; Levodopa; Male; Methanol; Necrosis; Parkinson Disease, Secondary; Respiratory Insufficiency; Tomography, X-Ray Computed | 2007 |
Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease.
Topics: Acute Disease; Antipsychotic Agents; Brief Psychiatric Rating Scale; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperazines; Psychoses, Substance-Induced; Thiazoles | 2008 |
Segmental action and stimuli-sensitive myoclonus with acute onset. A case report.
Topics: 5-Hydroxytryptophan; Acute Disease; Adult; Angiography; Carbidopa; Carotid Arteries; Cerebrovascular Circulation; Clonazepam; Diazepam; Electric Stimulation; Electroencephalography; Humans; Male; Myoclonus; Vertebral Artery | 1980 |
Dopaminergic therapy in acute encephalitis lethargica.
Topics: Acute Disease; Adolescent; Apomorphine; Carbidopa; Dopamine Agents; Dopamine Agonists; Female; Humans; Levodopa; Parkinson Disease, Postencephalitic | 1999 |
Treatment of acute and chronic portal encephalopathy with the precursors of dopamine.
Topics: Acute Disease; Adolescent; Adult; Aged; Carbidopa; Chronic Disease; Hepatic Encephalopathy; Humans; Middle Aged | 1979 |
Hypertensive crisis in a patient given sinemet, metoclopramide, and amitriptyline.
Topics: Acute Disease; Amitriptyline; Carbidopa; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrazines; Hypertension; Levodopa; Metoclopramide; Middle Aged; Parkinson Disease | 1977 |
Treatment of Sydenham's chorea with a combination of L-dopa and a peripheral dopa decarboxylase inhibitor.
Topics: Acute Disease; Adolescent; Carbidopa; Chorea; Drug Therapy, Combination; Homovanillic Acid; Humans; Hydrazines; Levodopa; Male; Recurrence | 1975 |
Painful Parkinson's disease.
Topics: Acute Disease; Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Administration Schedule; Drug Combinations; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Pain; Parkinson Disease; Time Factors | 1986 |
Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acute Disease; Adult; Carbidopa; Chronic Disease; Drug Combinations; Female; Humans; Levodopa; Male; Parkinson Disease; Pyridines; Substance-Related Disorders; Substantia Nigra | 1985 |